BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

786 related articles for article (PubMed ID: 8311117)

  • 1. Heparan sulfate proteoglycan in diffuse plaques of hippocampus but not of cerebellum in Alzheimer's disease brain.
    Snow AD; Sekiguchi RT; Nochlin D; Kalaria RN; Kimata K
    Am J Pathol; 1994 Feb; 144(2):337-47. PubMed ID: 8311117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunolocalization of heparan sulfate proteoglycans to the prion protein amyloid plaques of Gerstmann-Straussler syndrome, Creutzfeldt-Jakob disease and scrapie.
    Snow AD; Wight TN; Nochlin D; Koike Y; Kimata K; DeArmond SJ; Prusiner SB
    Lab Invest; 1990 Nov; 63(5):601-11. PubMed ID: 1977959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome.
    Snow AD; Mar H; Nochlin D; Sekiguchi RT; Kimata K; Koike Y; Wight TN
    Am J Pathol; 1990 Nov; 137(5):1253-70. PubMed ID: 2146882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agrin is a major heparan sulfate proteoglycan accumulating in Alzheimer's disease brain.
    Verbeek MM; Otte-Höller I; van den Born J; van den Heuvel LP; David G; Wesseling P; de Waal RM
    Am J Pathol; 1999 Dec; 155(6):2115-25. PubMed ID: 10595940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparan sulfate proteoglycan expression in cerebrovascular amyloid beta deposits in Alzheimer's disease and hereditary cerebral hemorrhage with amyloidosis (Dutch) brains.
    van Horssen J; Otte-Höller I; David G; Maat-Schieman ML; van den Heuvel LP; Wesseling P; de Waal RM; Verbeek MM
    Acta Neuropathol; 2001 Dec; 102(6):604-14. PubMed ID: 11761721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localization of heparan sulfate glycosaminoglycan and proteoglycan core protein in aged brain and Alzheimer's disease.
    Su JH; Cummings BJ; Cotman CW
    Neuroscience; 1992 Dec; 51(4):801-13. PubMed ID: 1488123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An important role of heparan sulfate proteoglycan (Perlecan) in a model system for the deposition and persistence of fibrillar A beta-amyloid in rat brain.
    Snow AD; Sekiguchi R; Nochlin D; Fraser P; Kimata K; Mizutani A; Arai M; Schreier WA; Morgan DG
    Neuron; 1994 Jan; 12(1):219-34. PubMed ID: 8292358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease.
    Snow AD; Mar H; Nochlin D; Kimata K; Kato M; Suzuki S; Hassell J; Wight TN
    Am J Pathol; 1988 Dec; 133(3):456-63. PubMed ID: 2974240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparan sulfate subdomains that are degraded by Sulf accumulate in cerebral amyloid ß plaques of Alzheimer's disease: evidence from mouse models and patients.
    Hosono-Fukao T; Ohtake-Niimi S; Hoshino H; Britschgi M; Akatsu H; Hossain MM; Nishitsuji K; van Kuppevelt TH; Kimata K; Michikawa M; Wyss-Coray T; Uchimura K
    Am J Pathol; 2012 May; 180(5):2056-67. PubMed ID: 22429964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microangiopathy and the colocalization of heparan sulfate proteoglycan with amyloid in senile plaques of Alzheimer's disease.
    Perlmutter LS; Chui HC; Saperia D; Athanikar J
    Brain Res; 1990 Jan; 508(1):13-9. PubMed ID: 2140065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential binding of vascular cell-derived proteoglycans (perlecan, biglycan, decorin, and versican) to the beta-amyloid protein of Alzheimer's disease.
    Snow AD; Kinsella MG; Parks E; Sekiguchi RT; Miller JD; Kimata K; Wight TN
    Arch Biochem Biophys; 1995 Jun; 320(1):84-95. PubMed ID: 7793988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Unifying Hypothesis of Alzheimer's Disease: Heparan Sulfate Proteoglycans/Glycosaminoglycans Are Key as First Hypothesized Over 30 Years Ago.
    Snow AD; Cummings JA; Lake T
    Front Aging Neurosci; 2021; 13():710683. PubMed ID: 34671250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sulfate content and specific glycosaminoglycan backbone of perlecan are critical for perlecan's enhancement of islet amyloid polypeptide (amylin) fibril formation.
    Castillo GM; Cummings JA; Yang W; Judge ME; Sheardown MJ; Rimvall K; Hansen JB; Snow AD
    Diabetes; 1998 Apr; 47(4):612-20. PubMed ID: 9568695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localization of perlecan (or a perlecan-related macromolecule) to isolated microglia in vitro and to microglia/macrophages following infusion of beta-amyloid protein into rodent hippocampus.
    Miller JD; Cummings J; Maresh GA; Walker DG; Castillo GM; Ngo C; Kimata K; Kinsella MG; Wight TN; Snow AD
    Glia; 1997 Oct; 21(2):228-43. PubMed ID: 9336237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel purification and detailed characterization of perlecan isolated from the Engelbreth-Holm-Swarm tumor for use in an animal model of fibrillar A beta amyloid persistence in brain.
    Castillo GM; Cummings JA; Ngo C; Yang W; Snow AD
    J Biochem; 1996 Aug; 120(2):433-44. PubMed ID: 8889831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between beta-amyloid protein and heparan sulfate proteoglycans from the cerebral capillary basement membrane in Alzheimer's disease.
    Shimizu H; Ghazizadeh M; Sato S; Oguro T; Kawanami O
    J Clin Neurosci; 2009 Feb; 16(2):277-82. PubMed ID: 19091577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparan sulfate expression patterns in the amyloid deposits of patients with Alzheimer's and Lewy body type dementia.
    Van Gool D; David G; Lammens M; Baro F; Dom R
    Dementia; 1993; 4(6):308-14. PubMed ID: 8136893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification in immunolocalization of a new class of proteoglycan (keratan sulfate) to the neuritic plaques of Alzheimer's disease.
    Snow AD; Nochlin D; Sekiguichi R; Carlson SS
    Exp Neurol; 1996 Apr; 138(2):305-17. PubMed ID: 8620929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accumulation of heparan sulfate proteoglycans in cerebellar senile plaques.
    van Horssen J; Kleinnijenhuis J; Maass CN; Rensink AA; Otte-Höller I; David G; van den Heuvel LP; Wesseling P; de Waal RM; Verbeek MM
    Neurobiol Aging; 2002; 23(4):537-45. PubMed ID: 12009503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffuse senile plaques occur commonly in the cerebellum in Alzheimer's disease.
    Joachim CL; Morris JH; Selkoe DJ
    Am J Pathol; 1989 Aug; 135(2):309-19. PubMed ID: 2675616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.